Allyson Fonte Application PackageFonte Allyson T
Last Name First Name Middle Initial
9 Island Avenue, APT 615 Miami Beach
Home Address City
FL 33139
State Zip Code
1305510439513055104395
HomeWork
act.fonte@yahoo.com
Email Address
13055104395
Cellular
Miami Beach
Business Address
9 Island Avenue
City
FL
State
33139
Zip Code
Occupation:Business Name:
Please list your preferences in order of ranking [1] first choice [2] second choice, and [3] third choice. Please note
that only three (3) choices will be observed by the City Clerk’s Office. (Regular Boards of City)
Choice 1:
Choice 2:
Choice 3:
Hispanic Affairs Committee
Parks and Recreational Facilities Board
Committee for Quality Education in Miami Beach
BOARD AND COMMITTEE
APPLICATION FORM
Note:If applying for the At-Large position of the Historic Preservation Board, please answer the below
questions:
Have you ever resided in one of the City's Historic Districts for at least one year?No
No Address in City Historic District submitted.
Professional License
No Professional Licenses Submitted.
Note:If you are seeking appointment to a professional seat (e.g. attorney, architect, etc.), you must attach a copy of
your currently effective corresponding professional license.
Pursuant to City Code section 2-22(4) a, b and c: Members of Agencies, Boards, and Committees shall be
affiliated with the city. This requirement shall be fulfilled in the following ways:
YesResident of the City for a minimum of six (6) months:
Demonstrate an ownership interest in a business established in the City for a minimum of six (6) months:No
AFFILIATION WITH THE CITY OF MIAMI BEACH
a.
● I am resident of:Middle Beach
Or
b.
"Ownership Interest" shall mean the ownership of ten percent (10%) or more (including the ownership of 10%
or more of the outstanding capital stock) in a business.
"Business" shall mean any sole proprietorship, sponsorship, corporation, limited liability company, or other
entity or business association.
c.Full-time employee of such a business (for a minimum of six months); and I am based in an office or
other location of the business that is physically located in Miami Beach (for a minimum of six months):No
Notwithstanding the requirements set forth herein, the qualified full-time employee of a business must be
approved by a 4/7th vote of the Mayor and City Commission.
NOTE: Members of Agencies, Boards, and Committees shall be required to demonstrate compliance with the City
affiliation requirements of section 2-22 (4) a and b of the Miami Beach City Code by executing an affidavit,
stipulating that they have met either (or both) of said affiliation requirements. The original affidavit shall be filled
with the Office of the City Clerk prior to being sworn in as a member.
Or
No● Have you ever been convicted of a felony:If yes, please explain in detail:
● Do you currently have a violation(s) of City of Miami Beach codes:No If yes, please explain in detail:
● Do you currently owe the City of Miami Beach any money:No If yes, please explain in detail:
● Are you currently serving on any City Boards or Committees:No If yes, which board?
● Are you presently a registered lobbyist with the City of Miami Beach?No
● I am applying for an appointment because I have special abilities, knowledge and experience. Please list below:
I am of Hispanic Heritage and have an interest in promoting diversity in the community
NOTE: IF APPOINTED, YOU WILL BE REQUIRED TO FOLLOW CERTAIN LAWS THAT APPLY TO CITY
BOARD/COMMITTEE MEMBERS. THESE LAWS INCLUDE, BUT ARE NOT LIMITED TO:
o Prohibition from directly or indirectly lobbying city personnel (Miami Beach City Code section 2-459).
o Prohibition from contracting with the city (Miami-Dade County Code section 2-11.1).
o Prohibition from lobbying before board/committee you have served on for period of one year after leaving office
(Miami Beach Code section 2-26)
o Requirement to disclose certain financial interests and gifts (Miami-Dade County Code section 2-11.1).
o Sunshine Law - Florida's Government-in-the-Sunshine Law was enacted in 1967. Today, the Sunshine Law
regarding open government can be found in Chapter 286 of the Florida Statutes. These statutes establish a basic
right of access to most meetings of Boards, Commissions, and other governing bodies of state and local
governmental agencies or authorities.
o Voting conflict - Form 8B is for use by any person serving at the county, city, or other local level of government on
an appointed or elected Board, Council, Commission, Authority, or Committee. It applies equality to members of
advisory and non-advisory bodies who are presented with a voting conflict of interest under Section 112.3143.
Florida Statutes.
● In what organization(s) in the City of Miami Beach do you currently hold membership in?
No Organization Information Submitted.
● List the address of all properties owned or in which you have an interest within the City of Miami Beach:
No Owned Property Information submitted.
If so, which department and title?No● Are you now employed by the City of Miami Beach:
● Pursuant to City Code Section 2-25 (b):
Do you have a parent, spouse, child, brother, or sister who is employed by the City of Miami Beach?No
If "Yes", identify person(s) and department(s):
No relative's information submitted.
BOARD & COMMITTEE FINANCIAL ACKNOWLEDGEMENT STATEMENT
Acknowledgement of fines/suspension for Board/Committee Members for failure to comply with
Miami-Dade County Financial Disclosure Code Section 2-11.1(i)(2)
I understand that no later than July 1, of each year all members of Boards and Committees of the City of Miami
Beach, including those of a purely advisory nature, are required to comply with Miami-Dade County Financial
Disclosure Requirements.
One of the following forms must be filled with the City Clerk of Miami Beach, 1700 Convention Center Drive,
Miami Beach, Florida, no later than 12:00 noon of July 1, of each year:
1. A "Source of Income Statement;" or
2. A "Statement of Financial Interests (Form 1)¹ ;" or
3. A Copy of your latest Federal Income Tax Return.
Failure to file one of these forms, pursuant to the Miami-Dade County Code, may subject the person to a fine of no
more than $500, 60 days in jail, or both.
_____________________________
¹ Members of the Planning Board and Board of Adjustment will be notified directly by the State of Florida, pursuant
to F.S. §112.3145(1)(a), to file a Statement of Financial Interests (Form 1) with the Miami-Dade County Supervisor of
Elections by 12:00 noon, July 1. Planning Board and Board of Adjustment members who file their Form 1 with the
County Supervisor of Elections automatically satisfy the County’s financial disclosure requirement as a Miami Beach
City Board/Committee member and need not file an additional form with the Office of the City Clerk. However,
compliance with the County disclosure requirement does not satisfy the State requirement.
DIVERSITY STATISTICS REPORT
The following information is voluntary and has no bearing on your consideration for appointment. It is being asked to
comply with City diversity reporting requirements.
OtherRace/Ethnic Categories
What is your race?
No details providedOther Description:
Gender:Female
Are you Spanish/Hispanic/ Latino? Mark the "No" box if not Spanish / Hispanic / Latino.Yes
Physically Challenged:No
I HEREBY ATTEST TO THE ACCURACY AND TRUTHFULNESS OF THE APPLICATION; AND I HAVE
RECEIVED, READ AND WILL ABIDE BY CHAPTER 2, ARTICLE VII, OF THE MIAMI BEACH CITY CODE,
ENTITLED “STANDARDS OF CONDUCT FOR CITY OFFICERS, EMPLOYEES AND AGENCY MEMBERS AND
ALL OTHER APPLICABLE COUNTY AND/OR STATE LAWS AND STATUTES ACCORDINGLY.”
I Allyson Fonte agreed to the following terms on 3/18/2021 12:48:31 PM
Received in the City Clerk's Office by:
Name of Deputy Clerk Control No. Date
Board and Committee Application Checklist: Please ensure you have provided all information before applying or
reapplying to any Board and Committee.
YES
YES
YES
YES
I have answered all questions fully.
I have uploaded a current resume, photograph, and a copy of any applicable professional license.
I have completed and attached the Board & Committee Financial Acknowledgment Statement.
I have completed and attached the Diversity Statistics Report.
If you have any questions, please contact the Office of the City Clerk via email: BC@miamibeachfl.gov or
telephone: 305.673.7411
Note: Florida Statutes 119.071: The role of the Office of the City Clerk is to receive and maintain forms filed as
public records. If your home address, telephone numbers, and/or photograph are exempt from disclosure and you
do not wish your home address, telephone numbers, and/or photograph to be made public, please:
1) Use your office or other address for your mailing address;
2) Use your office or other telephone number for your contact number; and
3) Do not attach a photograph.
A LLYSON T. F ONTE , P HARM .D.
9 Island Ave, Apt 615, Miami Beach, Fl 33139
[C] 305.510.4395 | act.fonte@yahoo.com
P ROFESSIONAL P RACTICE E XPERIENCE
Medical Science Liaison Jan 2021 - present
Seres Therapeutics, Inc
Supervisor: Michael Callahan, PhD
• Cover Southeast territory, including FL, GA, AL, MS, MS, NC, KY, and TN.
• Supporting launch of SER -109.
Medical Science Liaison Sep 2019 – Jan 2021
Shionogi Inc.
Supervisor: Jennifer Hayes, PharmD
• Covered Southeast territory, including FL, GA, AL, MS, and SC.
• Supported launch of cefiderocol, a novel siderophore cephalosporin antibiotic indicated for complicated
urinary tract infections (cUTI) and hospital-acquired bacterial pneumonia and ventilator -associated
bacterial pneumonia (HABP/VABP).
• Provided medical and scientific information and high -quality educational presentations, including
advisory board, and roundtable presentations.
• Maintained expertise in disease state management, emerging therapies and competitive landscape
across therapeutic area of infectious diseases, cUTI and HABP/VABP.
• Identified research opportunities, gather insights and competitive intelligence for internal strategies.
• Delivered internal and cross departmental assignments, including authoring standard response letters,
abstracts, and posters, and coordinating publications.
• Aided in identifying virtual opportunities for continued KOL engagement.
Medical Science Liaison Apr 2018 – Sep 2019
Tetraphase Pharmaceuticals
Supervisor: Kenneth Lawrence, PharmD
• Cover Southeast territory, including FL, GA, AL, MS, SC and NC.
• Supporting launch of eravacycline (Xerava), a fluorocycline IV antibiotic indicated for complicated intra -
abdominal infections (cIAI).
• Provide medical and scientific information and high -quality educational presentations, including advisory
board presentations.
• Member of Publication, Marketing Advisory and Scientific Research committees.
• Maintain expertise in disease state management, emerging therapies and competitive landscape across
therapeutic area of infectious diseases and cIAI.
• Identify research opportunities, gather insights and competitive intelligence for internal strategies.
• Deliver internal and cross departmental assignments, including authoring standard response letters,
abstracts, and posters, and coordinating publications.
• Initiated Quarterly Miami ASP committee meetings across Miami -Dade/Broward.
Medical Science Liaison Sep 2017 – Mar 2018
Teva Pharmaceuticals
Supervisor: Michael Seminerio, PhD
Allyson T. Fonte, Pharm.D.
Page - 2 - of 4
• Covered Florida and Puerto Rico.
• Maintained expertise in disease state management, emerging therapies and competitive landscape
across therapeutic area of headache/migraine.
• Engaged in scientific exchange with key opinion leaders, researchers and other healthcare professionals.
• Provided medical and scientific information and high -quality educational presentations.
• Identified research opportunities, gathered insights and competitive intelligence for internal strategies.
Medication Safety Officer /Manager May 2014 - Sep 2017
Clinical Coordinator, Infectious Disease Specialist Aug 2007 - Apr 2014
Mount Sinai Medical Center, Miami Beach, FL
Supervisor: Mukesh Shah, RPh, MBA
• Perform medication variance analysis, gap analysis, failure mode and effect analysis and develop action plans
involving multiple disciplines to reduce risk and improve patient safety and ensure Joint Commission
preparedness.
• Deliver drug information to health care professionals via educational lectures and in-services, and serve as the
pharmacy point person for institution owned physician practices.
• Developed and managed all aspects of the Antimicrobial Stewardship Program (ASP), including
prospective and retrospective interventions to maximize therapy and limit unintended consequences
associated with antimicrobials.
• Developed and maintained ASP dashboard for monitoring of antimicrobial utilization, days of therapy,
gram-negative multidrug resistant organism emergence (MDRO), Clostridium difficile rate, and
compilation of annual antibiogram.
• Created and managed updates for prescribing guidelines and clinical pathways for Sepsis, Pneumon ia,
and Surgical Prophylaxis to guide therapy in computerized physician order entry (CPOE) system .
• Daily clinical activities include d PK, renal dose adjustments and IV-PO conversions of targeted
antimicrobials, culture and susceptibility monitoring, and interdisciplinary rounding with ID team.
• Formulary decision maker tasked with identifying, implementing and managing various house-wide
formulary conversions and cost saving initiatives.
• Precept and mentor APPE and IPPE pharmacy students.
• Various committee involvements, including Secretary of Pharmacy & Therapeutics, Co-Chairperson of
Antimicrobial Stewardship, Chairperson of Medication Safety, Co-Chairperson of Medication Variance,
Member of Infection Control, Member of Patient Safety, and Member of Code Blue and Falls Committee.
• Author monthly P&T Highlights Newsletter and Safe Medicine Newsletter for house -wide communication.
• Principal research pharmacist for Alzheimer’s Clinic , responsible for investigational product ordering,
preparing, dispensing, accountability and staff education.
Pharmacy Practice Resident (PGY-1: Emphasis in ID/Critical Care) Jul 2006 - Jun 2007
Ryder Trauma Center at Jackson Memorial Hospital, Miami, FL
Supervisor: Eleanor Gomez-Fein, Pharm.D. & Ennie Cano, Pharm.D. BCPS
• Staffed every 3 rd weekend, performing order entry and clinical monitoring for intensive care units (ICUs).
• Rotated through various specialties, including multiple ICU s, Infectious Diseases, Internal Medicine ,
Ambulatory Care, Academia and Administration.
• Delivered drug information via formal and informal peer -to-peer interaction.
• Executed longitudinal research projects, medication utilization evaluation s, extensive literature review
and creation of institution specific prescribing guidelines and clinical pathways.
Pharmacy Technician Aug 2001 - Aug 2002
Mercy Hospital, Coconut Grove, FL
Allyson T. Fonte, Pharm.D.
Page - 3 - of 4
Supervisor: Rosaura Diaz, Pharm.D.
E DUCATIONAL E XPERIENCE
Doctor of Pharmacy Aug 2002 - May 2006
Nova Southeastern University, Fort Lauderdale, FL
Major of Biology 2000 - 2002
University of Miami, Miami, FL
Major of Biology 1998 - 2000
Vanderbilt University, Nashville, TN
L ICENSURE AND C ERTIFICATIONS
Clinical Affiliate Assistant Professor, Nova Southeastern University, 2008 - 2017
Clinical Affiliate Assistant Professor, Palm Beach Atlantic University, 2008 - 2017
Collaborative IRB Training Initiative (CITI), 2006, 2014, 2016
Registered Pharmacist, State of Florida, 2006 - present
Residency in Pharmacy Practice, Accredited by AS HP, 2006 - 2007
Licensed Pharmacy Intern, State of Florida, 2002 - 2006
P OSTERS P RESENTATIONS
Fonte A, Kolkin S, Lawrence K, Izmailyan S. Efficacy of Eravacycline in Obese Patients: Pooled Analysis of IGNITE1
and IGNITE4. Making a Difference in Infectious Disease Annual Meeting. Poster 74E. Orlando, FL. May 2019.
Kolkin S, Fonte A, Lawrence K, Izmailyan S. Effect of Renal Function in IGNITE1 and IGNITE4: Two Phase 3 Studies
to Evaluate the Efficacy and Safety of Eravacycline. Making a Difference in Infectious Disease Annual Meeting.
Poster 73E. Orlando, FL. May 2019.
Tsai L, Horn P, Solomkin J, Evans D, Gardovskis J, Fonte A. Results of IGNITE4: A Phase 3 Study to Evaluate the
Efficacy versus Meropenem in Complicated Intra-abdominal Infections. Making a Difference in Infectious Disease
Annual Meeting. Orlando, FL. May 2018.
P ROFESSIONAL M EMBERSHIPS
Infectious Diseases Society of America
Member 2018 - present
Making a Difference in Infectious Diseases
Member 2018 - present
Allyson T. Fonte, Pharm.D.
Page - 4 - of 4
Kappa Psi Pharmaceutical Fraternity Incorporated, Delta Rho Chapter
Member, 2002 - present
Pledge Class President, 2002
Pledge Master, 2003 and 2004
Florida Society of Health -System Pharmacists (FSHP)
Member, 2006 - present
American Pharmacists Association - Academy of Student Pharmacists (APhA -ASP)
Member, 2002 – 2006
ACCP, ID PRN
Member
G ENERAL S KILLS
Languages: read, write, and speak English and Spanish, fluently
Proficient in MS Office Programs
Proficient in Epic order entry system
Proficient in Omnicell medication dispensing system
Proficient in Accudose medication dispensing system